Skip to content

Michael Bloch

Partner

London

Bloch Michael
Michael Bloch

Partner

London

Michael has extensive experience in a wide range of corporate finance and equity capital markets transactions, including IPOs, public and private acquisitions and disposals and auction processes, and private equity transactions, frequently on a cross-border basis.

Michael has also spent seven months on secondment in the ECM business team at Credit Suisse, and has previously worked on secondment at ExxonMobil.

“Rising Star” IFLR1000 2019 (Equity Capital Markets)

“‘Very technically savvy,’ ‘easy to work with’ and ‘a good, safe pair of hands.’” Chambers UK 2020 (Equity Capital Markets)

"He is really impressive" Chambers UK 2021 (Capital Markets: Equity)

"He has good experience and he's a nice guy to deal with" Chambers UK 2021 (Capital Markets: Equity)

"Next Generation Partner" Legall 500 UK 2021 (Equity Capital Markets - Mid-High Cap)

Other noteworthy experience includes advising:

  • Kuwait Energy on its USD650m acquisition by United Energy Group by way of scheme of arrangement.
  • McCarthy & Stone on its GBP388m IPO on the premium main market of the London Stock Exchange (issuer's counsel)
  • Tullet Prebon on its reverse takeover acquisition of the global hybrid voice-broking and information business of ICAP plc.
  • Cobham on its GBP500m and GBP512m rights issues on the London Stock Exchange (issuer's counsel)
  • Equinity on its GBP317m IPO on the premium main market of the London Stock Exchange (underwriters counsel)
  • Circassia Pharmaceuticals ont its GBP580m IPO on the premium main market of the London Stock Exchange and GBP275m placing and open offer in connection with the acquisitions of Aerocrine and Prosonix (issuer's counsel).
  • Softcat on its GBP153m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
  • Spire Healthcare on its GBP842m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
  • Sensyne Health a digital healthcare company that develops regulated medical products and services using artificial intelligence, on its GBP225m IPO on the London Stock Exchange's AIM market.
  • Medopad on its Series A funding round to develop its healthcare technology data-capture platform.
 

News & insights

blue and orange night time shot of a cityscape

Publications: 26 MARCH 2021

Allen & Overy nel programma di commercial paper e cambiali finanziarie di Intesa Sanpaolo da 30 miliardi

Allen & Overy ha assistito Intesa Sanpaolo S.p.A. nel primo programma di commercial paper multiprodotto realizzato da una banca italiana che consente di emettere sia Euro-commercial paper (ECP) e…

Leggi di più
Fibre optic cable network

News: 16 MARCH 2021

Allen & Overy con BNL nella piattaforma di cartolarizzazione NPL

Allen & Overy ha assistito Banca Nazionale del Lavoro S.p.A. (BNL) nella strutturazione di una piattaforma di cartolarizzazione di crediti deteriorati originati da BNL e garantiti da asset…

Leggi di più

Publications: 10 MARCH 2021

Recenti sviluppi sull’applicazione di dlt all’emissione di strumenti finanziari (C.D. securities token)

Un’iniziativa di Consob per valutare l’utilizzo di securities token in Italia e la costruzione della relativa cornice normativa.

Leggi di più
Allen Overy nella nuova emissione da 1 miliardo di euro di Atlantia

News: 15 FEBRUARY 2021

Allen & Overy nella nuova emissione da 1 miliardo di euro di Atlantia

Allen & Overy ha assistito gli istituti finanziari nell’ambito della nuova emissione obbligazionaria di Atlantia per un ammontare complessivo pari a €1 miliardo. 

Leggi di più

Ufficio

London

Allen & Overy LLP
One Bishops Square
London
E1 6AD

View office →

Qualifiche

Titoli professionali

Admitted as solicitor, England and Wales, 2006

Titoli accademici

MA (Oxon), History, University of Oxford, 2002

Dip. Law, Nottingham Law School, 2003

LPC, Nottingham Law School, 2004

Esperienza in primo piano

Riconoscimenti